Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3112376 Target Snapshot

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 · SINGLE PROTEIN · Homo sapiens

97Compounds
23Assays
0Approved Drugs
96.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q96Q83. Use UniProt Q96Q83 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q96Q83 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 as ChEMBL target CHEMBL3112376, mapped to UniProt Q96Q83. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3112376
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q96Q83
Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 is the right protein anchor across sources, using UniProt Q96Q83 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-ketoglutarate-dependent dioxygenase alkB homolog 3
UniProt AccessionQ96Q83
Component TypeProtein
Sequence Length286 aa

Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3, mapped to UniProt Q96Q83. Sequence length is 286 aa.

Mapped IDQ96Q83
Review nameAlpha-ketoglutarate-dependent dioxygenase alkB homolog 3
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5095.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3145429 6.32 IC50 480.0 Preclinical
CHEMBL3145446 6.31 IC50 490.0 Preclinical
CHEMBL3145436 6.27 IC50 540.0 Preclinical
CHEMBL3145440 6.26 IC50 550.0 Preclinical
CHEMBL3145451 6.24 IC50 570.0 Preclinical
CHEMBL3145441 6.22 IC50 600.0 Preclinical
CHEMBL3145447 6.21 IC50 610.0 Preclinical
CHEMBL3145442 6.2 IC50 630.0 Preclinical
CHEMBL3145448 6.19 IC50 640.0 Preclinical
CHEMBL3115002 6.17 IC50 670.0 Preclinical
Distribution

pChEMBL Value Distribution

17
5.0
7
5.5
19
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

23
Total Assays
56
Tested Compounds
2
Assay Types
Binding — 22 assays, 56 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 18 47 5.6
cell-based format 3 9 4.8
assay format 1 0
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine